MX2016003914A - Dispositivo y metodo mejorados para prueba de embarazo. - Google Patents

Dispositivo y metodo mejorados para prueba de embarazo.

Info

Publication number
MX2016003914A
MX2016003914A MX2016003914A MX2016003914A MX2016003914A MX 2016003914 A MX2016003914 A MX 2016003914A MX 2016003914 A MX2016003914 A MX 2016003914A MX 2016003914 A MX2016003914 A MX 2016003914A MX 2016003914 A MX2016003914 A MX 2016003914A
Authority
MX
Mexico
Prior art keywords
test device
subject
pregnancy test
absolute
measure
Prior art date
Application number
MX2016003914A
Other languages
English (en)
Other versions
MX369321B (es
Inventor
Mccarthy David
Eapen Saji
Original Assignee
Spd Swiss Prec Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spd Swiss Prec Diagnostics Gmbh filed Critical Spd Swiss Prec Diagnostics Gmbh
Publication of MX2016003914A publication Critical patent/MX2016003914A/es
Publication of MX369321B publication Critical patent/MX369321B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Se da a conocer un dispositivo de prueba para detectar un embarazo en un sujeto humano femenino, comprendiendo el dispositivo de prueba: un medio de ensayo para medir la cantidad absoluta o relativa de hCG en una muestra del sujeto; un medio de ensayo para medir la cantidad absoluta o relativa de FSH en una muestra del sujeto; y un medio de ensayo para medir la cantidad absoluta o relativa de uno o más metabolitos de progesterona en una muestra del sujeto.
MX2016003914A 2013-10-02 2014-10-01 Dispositivo y metodo mejorados para prueba de embarazo. MX369321B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1317458.6A GB201317458D0 (en) 2013-10-02 2013-10-02 Improved pregnancy test device and method
PCT/GB2014/052960 WO2015049508A1 (en) 2013-10-02 2014-10-01 Improved pregnancy test device and method

Publications (2)

Publication Number Publication Date
MX2016003914A true MX2016003914A (es) 2016-10-21
MX369321B MX369321B (es) 2019-11-04

Family

ID=49585194

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016003914A MX369321B (es) 2013-10-02 2014-10-01 Dispositivo y metodo mejorados para prueba de embarazo.
MX2019013205A MX2019013205A (es) 2013-10-02 2016-03-28 Dispositivo y metodo mejorados para prueba de embarazo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019013205A MX2019013205A (es) 2013-10-02 2016-03-28 Dispositivo y metodo mejorados para prueba de embarazo.

Country Status (11)

Country Link
US (2) US10228377B2 (es)
EP (1) EP3052944B1 (es)
JP (2) JP6675976B2 (es)
CN (1) CN105765388B (es)
AU (2) AU2014330913B2 (es)
BR (1) BR112016007106A2 (es)
CA (1) CA2922890C (es)
GB (1) GB201317458D0 (es)
MX (2) MX369321B (es)
RU (2) RU2018142294A (es)
WO (1) WO2015049508A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10890590B2 (en) 2012-09-27 2021-01-12 Ellume Limited Diagnostic devices and methods
GB201317458D0 (en) 2013-10-02 2013-11-13 Spd Swiss Prec Diagnostics Gmbh Improved pregnancy test device and method
TWM503197U (zh) * 2014-12-31 2015-06-21 Yonglin Yonglin Biotech Corp 生理檢測裝置
WO2016115608A1 (en) * 2015-01-22 2016-07-28 Ellume Pty Ltd Diagnostic devices and methods for mitigating hook effect and use thereof
EP3278114A1 (en) * 2015-04-02 2018-02-07 Swiss Precision Diagnostics GmbH Improved pregnancy test device&method
JP6595818B2 (ja) * 2015-06-30 2019-10-23 田中貴金属工業株式会社 免疫クロマト分析装置及び免疫クロマト分析方法
CN205679626U (zh) * 2015-10-30 2016-11-09 杭州康永生物技术有限公司 一种测试电子笔
EP3335638A1 (en) * 2016-12-13 2018-06-20 Colorimetrix GmbH Method and device for estimation of ovulation date
US11131665B1 (en) 2018-08-22 2021-09-28 MFB Fertility, Inc. Method for evaluating urine of a subject to estimate the fertile window
US11029321B2 (en) 2017-02-17 2021-06-08 MFB Fertility, Inc. Method of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
US11061026B2 (en) 2017-02-17 2021-07-13 MFB Fertility, Inc. System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
CN106932598A (zh) * 2017-03-24 2017-07-07 南通伊仕生物技术股份有限公司 Hcg周期检测试剂盒及其制备方法
CN110785664A (zh) * 2017-04-28 2020-02-11 新加坡保健服务集团有限公司 流产中的特征性代谢物
CH713752B1 (fr) * 2017-05-24 2019-06-14 Palma Group S A Méthode d'identification d'écarts à la norme d'indices de l'urine.
JP2019113425A (ja) * 2017-12-25 2019-07-11 Ｂｌｕｅ Ｉｎｄｕｓｔｒｉｅｓ株式会社 イムノクロマトアッセイ用検査カートリッジ及び検査装置
EP3731751A4 (en) * 2017-12-28 2021-10-13 MFB Fertility, Inc. PROGESTERONE MONITORING SYSTEMS AND METHODS
KR102086141B1 (ko) * 2017-12-28 2020-04-29 주식회사 수젠텍 진단기, 진단용 디바이스 및 진단 방법
CN108387749A (zh) * 2018-03-07 2018-08-10 广州浩强生物科技有限公司 一种或受孕的检测方法及检测笔
CN108459167A (zh) * 2018-03-16 2018-08-28 江苏维尔生物科技有限公司 一种用于人体尿液中β-HCG、PDG定量检测的试剂盒及其制备方法
USD903897S1 (en) 2019-01-17 2020-12-01 Jamond Blake Dual indicator light pregnancy testing device
CN112740035A (zh) * 2018-07-27 2021-04-30 卢莫斯诊断Ip股份有限公司 侧流测定设备和使用方法
CN109324181B (zh) * 2018-10-22 2021-10-08 河北特温特生物科技发展有限公司 一种免疫层析用封闭剂组合物、用途、及免疫层析试剂盒的制备方法
GB201905090D0 (en) * 2019-04-10 2019-05-22 Spd Swiss Prec Diagnostics Gmbh Assay device
CN111141917A (zh) * 2019-12-19 2020-05-12 云奥生物科技(常州)有限公司 孕酮和β-hCG的二联层析检测卡及其制备方法和检测方法
EP4136449A1 (de) 2020-04-16 2023-02-22 Senova Gesellschaft für Biowissenschaft und Technik mbH Lateral flow assay
IT202000009154A1 (it) 2020-04-27 2021-10-27 Zenares S R L Dispositivo di auto-test monouso con funzionalità di auto-certificazione e kit contenente il medesimo
US20210387187A1 (en) 2020-05-27 2021-12-16 University Of Warwick Flow device
KR102534911B1 (ko) * 2020-10-23 2023-05-19 한국기술교육대학교 산학협력단 임신 진단용 스캐너 및 이를 이용한 임신 진단결과 표시 방법
US20240053362A1 (en) * 2020-12-08 2024-02-15 Varun Akur Venkatesan DYNAMIC MONITORING OF E3G, LH, PdG, FSH LEVELS IN FEMALE SUBJECTS TO PREDICT HEALTH CONDITIONS
CN112698027B (zh) * 2020-12-14 2022-04-01 广东唯实生物技术有限公司 一种半抗原免疫层析检测试剂
US20230173485A1 (en) 2021-02-28 2023-06-08 Uchenna Nkechi Chukwu Methods and devices for covid-19 testing using urine samples
US11921076B1 (en) 2021-02-28 2024-03-05 Uchenna Chukwu Methods and devices for COVID-19 testing using urine samples
GB202103200D0 (en) 2021-03-08 2021-04-21 Terasom S R O Lung Cancer diagnosis
USD1023336S1 (en) * 2023-02-16 2024-04-16 Andon Health Co., Ltd. Instrument and utensil for medical or laboratory diagnosis

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450239A (en) * 1981-09-23 1984-05-22 Northwestern University Method of determining pregnanediol in female urine and test device for use therein
EP1248112A3 (en) 1987-04-27 2004-08-25 Inverness Medical Switzerland GmbH Immunochromatographic specific binding assay device
US5663054A (en) * 1995-03-03 1997-09-02 Abbott Laboratories Determination of steroids by competitive immunoassay
US5786220A (en) 1995-04-28 1998-07-28 Quidel Corporation Assays and devices for distinguishing between normal and abnormal pregnancy
US5679584A (en) 1995-05-03 1997-10-21 Mileaf; Daryl Sunny Method for chemical detection
IL121279A (en) 1996-07-16 2001-05-20 Roche Diagnostics Gmbh An analytical system with means for testing samples with too small volumes
DE19639227B4 (de) 1996-09-24 2006-11-23 Lre Technology Partner Gmbh Verfahren und Vorrichtung zur Blutzuckermessung
US6194222B1 (en) 1998-01-05 2001-02-27 Biosite Diagnostics, Inc. Methods for monitoring the status of assays and immunoassays
GB9807134D0 (en) 1998-04-02 1998-06-03 Unilever Plc Test methods devices and test kits
GB2335983A (en) * 1998-04-02 1999-10-06 Unilever Plc Estimating time of maximum fertility
US20060019404A1 (en) * 1998-05-06 2006-01-26 Blatt Joel M Quantitative assay with extended dynamic range
US20050130311A1 (en) * 2001-09-18 2005-06-16 John Coley Detection of impaired fertility
JP3717158B2 (ja) 2001-11-09 2005-11-16 本田技研工業株式会社 油圧バルブ
JP4608213B2 (ja) 2002-01-09 2011-01-12 アレル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 液体試料分析デバイス
DE10211818B4 (de) 2002-03-16 2006-07-06 peS Gesellschaft für medizinische Diagnose-Systeme mbH Verfahren zur quantitativen Bestimmung mehrerer Analyten
US7090802B1 (en) * 2002-09-05 2006-08-15 Phenogenomics Corporation Sampling assembly for simultaneously testing a liquid biological sample for a plurality of hormones and method thereof
AU2003277309A1 (en) * 2002-10-08 2004-05-04 Tara Nylese Portable diagnostic device and method for determining temporal variations in concentrations
EP1565207B1 (en) * 2002-11-25 2006-04-12 Octapharma AG Prekallikrein depleted plasma derived albumin fraction
DK1484601T3 (da) * 2003-06-04 2009-06-08 Inverness Medical Switzerland Optisk indretning til et assay-aflæsningsapparat
CA2468014C (en) 2003-06-04 2016-03-22 Inverness Medical Switzerland Gmbh Flow sensing for determination of assay results
US7239394B2 (en) 2003-06-04 2007-07-03 Inverness Medical Switzerland Gmbh Early determination of assay results
US7572639B2 (en) 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
US20100035245A1 (en) 2005-08-31 2010-02-11 Egomedical Technologies Ag Analyte test system using non-enzymatic analyte recognition elements
RU2398235C2 (ru) * 2005-08-31 2010-08-27 Эгомедикаль Технологиз Аг Тест-система с использованием элементов неэнзиматического распознавания анализируемого вещества
GB0717043D0 (en) * 2007-04-10 2007-10-10 Inverness Medical Switzerland Assay device
GB0706906D0 (en) * 2007-04-10 2007-05-16 Inverness Medical Switzerland Assay device
NZ570601A (en) 2007-09-01 2009-11-27 Inverness Medical Switzerland Assay device with shared zones
GB0717045D0 (en) * 2007-09-01 2007-10-10 Inverness Medical Switzerland Assay device with shared zones
GB2460660B (en) 2008-06-04 2013-05-22 Alere Switzerland Gmbh Assay reader device & method for measuring hCG
GB0820999D0 (en) 2008-11-17 2008-12-24 Menon Johansson Anatole S Pregnancy testing
US20100129935A1 (en) * 2008-11-25 2010-05-27 Sarah Daniel Maddison Pregnancy testing method
US20120106464A1 (en) 2010-10-27 2012-05-03 The Hong Kong University Of Science And Technology Spectrum sharing with implicit power control in cognitive radio networks
US9638704B2 (en) 2010-11-24 2017-05-02 Spd Swiss Precision Diagnostics Gmbh Assay device
US9939385B2 (en) 2011-09-09 2018-04-10 Church & Dwight Co., Inc. Systems, methods, and test kits for analyte variation detection
US9588113B2 (en) * 2012-02-22 2017-03-07 Church & Dwight Co., Inc. Methods for electronic analyte assaying
GB201209664D0 (en) 2012-05-30 2012-07-11 Spd Swiss Prec Diagnostics Gmbh Assay device
CA2924217A1 (en) 2012-09-27 2014-04-03 Ellume Pty Ltd Diagnostic devices and methods
GB201317458D0 (en) * 2013-10-02 2013-11-13 Spd Swiss Prec Diagnostics Gmbh Improved pregnancy test device and method
EP3278114A1 (en) * 2015-04-02 2018-02-07 Swiss Precision Diagnostics GmbH Improved pregnancy test device&method

Also Published As

Publication number Publication date
GB201317458D0 (en) 2013-11-13
US10228377B2 (en) 2019-03-12
CA2922890A1 (en) 2015-04-09
EP3052944B1 (en) 2019-08-14
US20190204334A1 (en) 2019-07-04
RU2674266C2 (ru) 2018-12-06
RU2016116771A3 (es) 2018-03-05
CN105765388B (zh) 2018-04-20
JP6675976B2 (ja) 2020-04-08
CA2922890C (en) 2022-03-01
AU2014330913A1 (en) 2016-04-07
MX2019013205A (es) 2020-01-21
US11099199B2 (en) 2021-08-24
JP2016532077A (ja) 2016-10-13
AU2019284096B2 (en) 2020-10-29
JP2019023647A (ja) 2019-02-14
EP3052944A1 (en) 2016-08-10
RU2018142294A3 (es) 2019-09-03
BR112016007106A2 (pt) 2017-08-01
AU2019284096A1 (en) 2020-01-23
RU2018142294A (ru) 2018-12-10
US20150094227A1 (en) 2015-04-02
RU2016116771A (ru) 2017-11-13
AU2014330913B2 (en) 2020-01-30
WO2015049508A1 (en) 2015-04-09
CN105765388A (zh) 2016-07-13
MX369321B (es) 2019-11-04

Similar Documents

Publication Publication Date Title
MX2019013205A (es) Dispositivo y metodo mejorados para prueba de embarazo.
SG11201601668PA (en) Assay test device, kit and method of using
EP3152557A4 (en) Low cost test strip and method to measure analyte
EP3039517A4 (en) Latency measuring and testing system and method
EP3032250A4 (en) Substance measurement method and measurement device employing electrochemical biosensor
EP3037827A4 (en) Probe pin and electronic device using same
WO2014144355A3 (en) Anti-gp73 monoclonal antibodies and methods of obtaining the same
MX2015014485A (es) Dispositivo de transferencia de muestreo de fluidos biologicos y sistema de separacion y analisis de fluidos biologicos.
MX369604B (es) Dispositivo de transferencia de muestras de sangre y sistema de separacion y analisis de sangre.
IN2014DE01077A (es)
EP2963418A4 (en) DEVICE AND METHOD FOR ANALYZING URINE SAMPLES
TR201907737T4 (tr) Test numunesi desteği ve çarpışma testi aparatı ve destek kullanılarak yapısal elemanın çarpışma testi yöntemi.
WO2015007153A3 (en) An immunoassay reading device and its calibration method
GB2540907A (en) Continuity test system and method
GB2545850A (en) System and method using a combined modality optical probe
GB2534035A (en) Image processing method and system
EP3295174A4 (en) METHOD FOR REUSING A TEST PROBE AND REAGENTS IN IMMUNODOSIS
MX2015015015A (es) Metodo para diagnosticar cancer.
NZ720608A (en) Β-glucan assay methods
GB201200413D0 (en) Analysis system for test artifact generation
SG10201901836PA (en) Test strip assembly
EP2943793A4 (en) PROCEDURE FOR A DECISION CONCERNING THE PERFORMANCE OF A TESTS OF A CROWN NECK CARTOON ON A NUTRITIONAL CANCER AND DEVICES AND KITS FOR THE IMPLEMENTATION OF THE PROCEDURE
IL227524A0 (en) A device and method for the analysis of multiple anal
FR3004805B1 (fr) Eprouvette de mesure de traction, de compression et/ou de cisaillement
EP3454060A4 (en) ANALYSIS METHOD AND ANALYSIS DEVICE FOR A SUBSTANCE TO BE MEASURED

Legal Events

Date Code Title Description
FG Grant or registration